Canada · Health Canada Drug Product Database
MORPHINE SULFATE
Source ingredient · 153 source records
Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.
MS CONTIN TABLETS
Tablet (Extended-Release) / PURDUE PHARMA
MS CONTIN XL CAPSULES
Capsule (Sustained-Release) / PURDUE PHARMA
MS CONTIN XL CAPSULES
Capsule (Sustained-Release) / PURDUE PHARMA
MS CONTIN XL CAPSULES
Capsule (Sustained-Release) / PURDUE PHARMA
MS CONTIN XL CAPSULES
Capsule (Sustained-Release) / PURDUE PHARMA
MS CONTIN XL CAPSULES
Capsule (Sustained-Release) / PURDUE PHARMA
MS CONTIN XL CAPSULES
Capsule (Sustained-Release) / PURDUE PHARMA
MS IR SUP 30MG
Suppository / PURDUE PHARMA
MS IR SUP 10MG
Suppository / PURDUE PHARMA
MS IR SUP 20MG
Suppository / PURDUE PHARMA
MS.IR
Tablet (Immediate-Release) / PURDUE PHARMA
MS.IR
Tablet (Immediate-Release) / PURDUE PHARMA
MS.IR
Tablet (Immediate-Release) / PURDUE PHARMA
MS.IR
Tablet (Immediate-Release) / PURDUE PHARMA
NTP-MORPHINE SR
Tablet (Extended-Release) / TEVA CANADA LIMITED
NTP-MORPHINE SR
Tablet (Extended-Release) / TEVA CANADA LIMITED
NTP-MORPHINE SR
Tablet (Extended-Release) / TEVA CANADA LIMITED
NTP-MORPHINE SR
Tablet (Extended-Release) / TEVA CANADA LIMITED
NTP-MORPHINE SR
Tablet (Extended-Release) / TEVA CANADA LIMITED
ORAMORPH SR TABLETS 100MG
Tablet (Extended-Release) / ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM
ORAMORPH SR TABLETS 30MG
Tablet (Extended-Release) / ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM
ORAMORPH SR TABLETS 60MG
Tablet (Extended-Release) / ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM
PMS-MORPHINE SULFATE
Tablet / PHARMASCIENCE INC
PMS-MORPHINE SULFATE
Tablet / PHARMASCIENCE INC
PMS-MORPHINE SULFATE
Tablet / PHARMASCIENCE INC
PMS-MORPHINE SULFATE
Tablet / PHARMASCIENCE INC
PMS-MORPHINE SULFATE IR
Tablet (Immediate-Release) / PHARMASCIENCE INC
PMS-MORPHINE SULFATE IR
Tablet (Immediate-Release) / PHARMASCIENCE INC
PMS-MORPHINE SULFATE IR
Tablet (Immediate-Release) / PHARMASCIENCE INC
PMS-MORPHINE SULFATE IR
Tablet (Immediate-Release) / PHARMASCIENCE INC